Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML

NCT05805098 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Venetoclax
DRUG: Homoharringtonine
DRUG: Cytarabine

Sponsor

The First Affiliated Hospital of Soochow University